Oncology News Central (@oncnewscentral) 's Twitter Profile
Oncology News Central

@oncnewscentral

Oncology News Central (ONC) is the single destination for oncologists to stay abreast of the rapidly changing oncology landscape.

ID: 615435338

linkhttps://www.oncologynewscentral.com calendar_today22-06-2012 18:57:40

8,8K Tweet

1,1K Takipçi

798 Takip Edilen

Oncology News Central (@oncnewscentral) 's Twitter Profile Photo
Oncology News Central
@oncnewscentral

a year ago

Study MARIPOSA: FDA approves amivantamab-vmjw + lazertinib as first-line for EGFR+ NSCLC. Superior PFS over osimertinib! New standard of care? bit.ly/3yC9cFl #NSCLC IASLC NEJM Alex Spira, M.D.